Share-based Payment Arrangement, Expense of Alzamend Neuro, Inc. from 30 Apr 2020 to 30 Apr 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Alzamend Neuro, Inc. annual and quarterly Share-based Payment Arrangement, Expense in USD history and change rate from 30 Apr 2020 to 30 Apr 2025.
  • Alzamend Neuro, Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Jan 2025 was $81,277, a 56% decline year-over-year.
  • Alzamend Neuro, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $325,108, a 66% decline from 2023.
  • Alzamend Neuro, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $955,633, a 73% decline from 2022.
  • Alzamend Neuro, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $3,582,625, a 19% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)

Alzamend Neuro, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $325,108 -$630,525 -66% 01 May 2024 30 Apr 2025 10-K 22 Jul 2025 2025 FY
2023 $955,633 -$2,626,992 -73% 01 May 2023 30 Apr 2024 10-K 22 Jul 2025 2025 FY
2022 $3,582,625 -$825,944 -19% 01 May 2022 30 Apr 2023 10-K 30 Jul 2024 2024 FY
2021 $4,408,569 +$1,997,506 +83% 01 May 2021 30 Apr 2022 10-K 27 Jul 2023 2023 FY
2020 $2,411,063 +$155,823 +6.9% 01 May 2020 30 Apr 2021 10-K 19 Jul 2022 2022 FY
2019 $2,255,240 01 May 2019 30 Apr 2020 10-K 29 Jul 2021 2021 FY

Alzamend Neuro, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $81,277 -$105,363 -56% 01 Nov 2024 31 Jan 2025 10-Q 10 Mar 2025 2024 Q3
Q3 2024 $81,277 -$94,456 -54% 01 Aug 2024 31 Oct 2024 10-Q 11 Dec 2024 2024 Q2
Q4 2023 $186,640 -$1,321,682 -88% 01 Nov 2023 31 Jan 2024 10-Q 10 Mar 2025 2024 Q3
Q3 2023 $175,733 -$539,906 -75% 01 Aug 2023 31 Oct 2023 10-Q 11 Dec 2024 2024 Q2
Q1 2023 $3,582,625 $491,326 -$766,442 -61% 01 Feb 2023 30 Apr 2023 10-K 30 Jul 2024 2024 FY
Q4 2022 $4,349,067 $1,508,322 +$377,527 +33% 01 Nov 2022 31 Jan 2023 10-Q 25 Mar 2024 2024 Q3
Q3 2022 $3,971,540 $715,639 -$564,745 -44% 01 Aug 2022 31 Oct 2022 10-Q 15 Dec 2023 2024 Q2
Q2 2022 $4,536,285 $867,338 +$127,716 +17% 01 May 2022 31 Jul 2022 10-Q 13 Sep 2022 2022 Q1
Q1 2022 $4,408,569 $1,257,768 +$582,202 +86% 01 Feb 2022 30 Apr 2022 10-K 27 Jul 2023 2023 FY
Q4 2021 $3,826,367 $1,130,795 +$555,668 +97% 01 Nov 2021 31 Jan 2022 10-Q 15 Mar 2023 2023 Q3
Q3 2021 $3,270,699 $1,280,384 +$711,447 +125% 01 Aug 2021 31 Oct 2021 10-Q 12 Dec 2022 2022 Q2
Q2 2021 $2,559,252 $739,622 +$148,189 +25% 01 May 2021 31 Jul 2021 10-Q 13 Sep 2022 2022 Q1
Q1 2021 $2,411,063 $675,566 01 Feb 2021 30 Apr 2021 10-K 19 Jul 2022 2022 FY
Q4 2020 $575,127 01 Nov 2020 31 Jan 2021 10-Q 15 Mar 2022 2022 Q3
Q3 2020 $568,937 01 Aug 2020 30 Oct 2020 10-Q 13 Dec 2021 2022 Q2
Q2 2020 $591,433 01 May 2020 31 Jul 2020 10-Q 13 Sep 2021 2022 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.